Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms
Various antimuscarinic agents have been developed for the treatment of overactive bladder (OAB). More data comparing these agents are still required. This study evaluated the efficacy and safety of solifenacin and tolterodine in Taiwanese patients with OAB symptoms. Methods: This was a prospective,...
Main Authors: | Chen-Hsun Ho, Ting-Chen Chang, Ho-Hsiung Lin, Shih-Ping Liu, Kuo-How Huang, Hong-Jeng Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-10-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664610601143 |
Similar Items
-
Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis
by: Sergio Iannazzo, et al.
Published: (2008-03-01) -
Clinical Experience of the Use of Tolterodine in Patients with Overactive Bladder at Siriraj Hospital
by: Vitaya Titapant, et al.
Published: (2020-08-01) -
Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013-09-01) -
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
by: Danny Ulahannan, et al.
Published: (2009-04-01) -
Persistence and adherence of solifenacin treatment for Japanese women with overactive bladder
by: Minoru Kobayashi, et al.
Published: (2012-10-01)